THE SEARLE COMPANY LIMITED

Aizaz Latif 23086

Waqar Ahmed Siddiqui 23204
Kashif Rasool 23683
VISION AND MISSION

 Vision
 To lead in improving the quality of human life.
 Our Mission
 Which provides its customers with the best possible products
and services in the Healthcare and Consumer Industry
 That is ever evolving in-step with the changing market place
to maintain its leadership role.
 Which is a responsible corporate citizen contributing to
society and protecting the environment.
 That promotes team spirit amongst its employees whilst
maintaining their individuality, in a culture where people are
encouraged to think and strive to achieve their true potential.
 This cares for its employees and shares in their dreams.
 Which works today for a better and secure tomorrow for all its
stake holders through innovation, new product development
and sound business practices?
 Which would grow and live beyond each one of us.
INTERVIEW WITH…
 Aquil Ahmed
 Regulatory laison Manager Islamabad,

 Department (R&D Regulatory )

 Lasioning with DRAP offical

 To register Product

 Having knowledge about new regulatory act

 Keeping eye on competitor strategies

PRODUCT & SERVICES
 Respiratory (cough syrup,antiallergey )
 Consumer Health and Nutrition

 Cardio vascular (Anti hepatitis )

 Antibiotic

International Operation
Afghanistan
Sri lanka
Bangladesh
Philippines
Uganda
Myanmar
Azerbaijan
INTERNATIONAL OPERATION
 Afghanistan
 Sri lanka

 Bangladesh

 Philippines

 Uganda

 Myanmar

 Azerbaijan
CHALLENGES FACED IN INTERNATIONAL
VENTURE

 Regulatory (rules and Regulation )

 Market Size ( population)

 Law and order

 Buying Power

Mode Of International Entry & Operation

 Joint venture
 Acquisition

 Distributor
STRATEGIC MARKETING PLAN
SWOT ANALYSIS

 Strengths
 The strengths of the SEARLE could include low operating overhead,
firm fiscal management, low staff turnover, high return on
investment (ROI), state-of-the-art laboratory equipment and an
experienced research staff.
 Weaknesses
 The SEARLE industry’s weaknesses could include high-risk business
modeling disengaged Board of Directors, dated medical equipment,
poor branding, low staff morale or diseconomies of scale.
 Opportunities
 The SEARLE industry’s Opportunities could include recently
published research, an increase in health-conscious consumers,
increased demand for pharmaceutical products, changes in Food and
Drug Administration standards or decreases in employee health care
costs.
 Threats
 The SEARLE industry’s threats could include increased government
regulation, a declining economy, increasing research and development
(R&D) costs or a decrease in the global population.
STRATEGIC OBJECTIVES OF SEARLE

 To reduce cost by improving supply and

distribution
 To increase earnings per share To improve
productivity and eliminations of waste
 To gain market share by acquiring competitor

 To improve the quality of existing products

FUNCTIONAL STRATEGIES

 R&D Improve formula of existing products

 Supply Chain Strategic Depots

 Marketing New Packaging

 Finance Department Generate finance through

equity
 Rivalry among Competing Firm
 High Number of Competing Firms: There are number of
pharmaceutical firms operating in Pakistan. That’s why
rivalry among competing firms is very high. Both local and
multinational companies have their operations in Pakistan
Similar capability of firms competing Local as well as MCN
companies have same capabilities. On this basis we can say
rivalry among competing firm is high. When consumers can
switch brands easily Consumer can switch brand easily.
Switching cost is almost ignorable which shows there is
high rivalry among competing firms.
 Threats of New Entrants
 Capital Requirements Capital requirement in
pharmaceuticals industry is very high. so threats of new
entrant are low. Economies of Scale In Pakistan
pharmaceutical industry, to achieve economies of scale
quickly is very difficult due to lack of technology and
human resources. So threats of new entrant are low
 Threats of Substitute
 Relative Prices of Substitute Products: Homeopathic
medicines are first choice Pakistani people because
prices of these medicines are low. So threats of
substitute are high in pharmaceutical industry
 Bargaining Power of Supplier
 Number of Suppliers: Local Suppliers There are
numerous suppliers of pharmaceutical products in
Pakistan so bargaining power of supplier is low.
International Suppliers: It is found in an interview
the companies import raw material and finish goods
items from different countries around the world. It
means bargaining power of supplier is low.
 Bargaining Power of Customers
 Inexpensively Switch to Competing Brands or
Substitutes: Switching cost for costumers is low.
Pakistan is importing medicine from different
countries. To switch from local brand to imported
brand is becoming common in Pakistan.
TAKING CARE OF ISSUES OF ETHICS
 Seeking Allah’s pleasure in all that we do
Innovation and dedication in all spheres of
activity. Serving the needs of our customers with
passion dedication & by honoring our words.

 To drive each individual to achieve company’s

objectives. Integrity: in all our dealings. Respect:
for our customers and each other.